Corbus Pharmaceuticals (CRBP) announced that the abstract for its first-in-human dose escalation clinical study conducted in the United States ...

Other data highlights include a poster presentation underscoring ... as well as an encore oral presentation summarizing neurological, skeletal, and other clinical outcomes from a proof-of-concept ...

Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions. By optimizing every component of its product ...

Results from GALILEO-1, a first in human clinical trial of FLT201 AAV-gene therapy in adult patients with Gaucher disease type 1 (Poster #318) Session: Poster Session III Date & Time: Thursday, ...

And finally, in the fourth quarter of 2024, the company announced positive results from a 28-day Phase 1b clinical ... This presentation highlighted data showing that cohorts receiving VK2735 ...

Initiation of Phase 3 Studies for Subcutaneous VK2735 ... in vivo data from this program at the American Diabetes Association's (ADA's) Annual Scientific Sessions. The company's presentation ...

Alexander Medical Student Research Symposium was established in 2000 to provide a formal mechanism in which Baylor College of Medicine medical students can present meaningful research in either ...